Trial Profile
Prospective Analysis of Liver Cancer Treatment and Interventions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Sep 2013 Planned End Date changed from 1 Aug 2016 to 1 Nov 2014 as reported by ClinicalTrials.gov
- 10 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
- 25 Oct 2012 Planned End Date changed from 1 Aug 2011 to 1 Aug 2016 as reported by ClinicalTrials.gov.